Tuesday 28 October 2014

PPMD Submits Letter to FDA Regarding Latest Sarepta Update - PPMD Community

PPMD Submits Letter to FDA Regarding Latest Sarepta Update - PPMD Community: "Today’s press release and investor call from Sarepta have sent a ripple of angst and sadness through our community. Moments ago, PPMD sent a letter to the FDA that reflects our organization’s belief that safety and rigor have been demonstrated throughout this process. Further, we believe that any strengthening of data packages that causes delays (as is now being requested by the FDA, as articulated in today’s press release and call) should ensure a streamlined, more expeditious approval process for follow-on exons."



'via Blog this'

No comments:

Post a Comment